The PE ratio for Resmed stock stands at 28.06 as of Jun 18, 2025. This is calculated based on the TTM EPS of $8.94 and the stock price of $250.88 per share. The current PE ratio is about the same compared to the last four quarters average.
Over the last ten years, the average PE ratio of Resmed has been 38.32. The current 28.06 P/E ratio is 27% lower than the historical average. Looking back at the last ten years, RMD's PE ratio peaked in the Sep 2021 quarter at 76.39, with a price of $263.55 and an EPS of $3.45. The Sep 2015 quarter marked the lowest point at 20.3, with a price of $50.96 and an EPS of $2.51.
Maximum annual increase: 69.23% in 2021
Maximum annual decrease: -47.92% in 2022
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 27.58 | -22.75% | $191.42 | $6.94 |
2023 | 35.7 | -9.07% | $218.5 | $6.12 |
2022 | 39.26 | -47.92% | $209.63 | $5.34 |
2021 | 75.39 | 69.23% | $246.52 | $3.27 |
2020 | 44.55 | 3.32% | $192 | $4.31 |
2019 | 43.12 | -8% | $122.03 | $2.83 |
2018 | 46.87 | 45.65% | $103.58 | $2.21 |
2017 | 32.18 | 27.75% | $77.87 | $2.42 |
2016 | 25.19 | 12.15% | $63.23 | $2.51 |
2015 | 22.46 | 8.24% | $56.37 | $2.51 |
2014 | 20.75 | -1.14% | $50.63 | $2.44 |
2013 | 20.99 | 17.72% | $45.13 | $2.15 |
2012 | 17.83 | -14.16% | $31.2 | $1.75 |
2011 | 20.77 | -13.92% | $30.95 | $1.49 |
2010 | 24.13 | 14.96% | $30.41 | $1.26 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 25.04 | -7.05% | $223.85 | $8.94 |
Dec 2024 | 26.94 | -16.57% | $228.69 | $8.49 |
Sep 2024 | 32.29 | 17.08% | $244.12 | $7.56 |
Jun 2024 | 27.58 | -9.19% | $191.42 | $6.94 |
Mar 2024 | 30.37 | 6.97% | $198.03 | $6.52 |
Dec 2023 | 28.39 | 18.44% | $172.02 | $6.06 |
Sep 2023 | 23.97 | -32.86% | $147.87 | $6.17 |
Jun 2023 | 35.7 | -3.98% | $218.5 | $6.12 |
Mar 2023 | 37.18 | -1.22% | $218.99 | $5.89 |
Dec 2022 | 37.64 | -7.24% | $208.13 | $5.53 |
Sep 2022 | 40.58 | 3.36% | $218.3 | $5.38 |
Jun 2022 | 39.26 | -13.39% | $209.63 | $5.34 |
Mar 2022 | 45.33 | -37.53% | $242.51 | $5.35 |
Dec 2021 | 72.56 | -5.01% | $260.48 | $3.59 |
Sep 2021 | 76.39 | 1.33% | $263.55 | $3.45 |
Currently, RMD's PE ratio is lower than its 3, 5 and 10-year averages.
RMD's PE ratio stands higher than its peer stocks TMO and MDT.
Stock name | PE ratio | Market cap |
---|---|---|
TMO Thermo Fisher Scientific Inc | 22.97 | $148.19B |
ELMD Electromed Inc | 24.99 | $173.93M |
MDT Medtronic plc | 25.9 | $109.95B |
RMD Resmed Inc | 28.06 | $36.79B |
MASI Masimo Corp | N/A | $8.83B |
INGN Inogen Inc | N/A | $177.46M |
RMD's price to earnings ratio is 28.06 as of Jun 18, 2025.
As an average over the last 3 years, RMD stock has a PE ratio of 32.08.
As an average over the last 5 years, RMD stock has a PE ratio of 42.05.
Over the last ten years, the Sep 2021 quarter recorded the highest quarterly PE ratio at 76.39.
The current PE ratio of RMD is 27% lower than the 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 18, 2025), Resmed's share price is $250.88. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $8.94. Therefore, Resmed's PE ratio for today is 28.06. PE RATIO(28.06) = STOCK PRICE($250.88) / TTM EPS($8.94)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.